Bactericidal Activity of an Imidazo[1, 2-a]pyridine Using a Mouse M. tuberculosis Infection Model
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Bactericidal Activity of an Imidazo[1, 2-a]pyridine Using a Mouse M. tuberculosis Infection Model
Authors
Keywords
-
Journal
PLoS One
Volume 9, Issue 1, Pages e87483
Publisher
Public Library of Science (PLoS)
Online
2014-02-01
DOI
10.1371/journal.pone.0087483
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Discovery of Q203, a potent clinical candidate for the treatment of tuberculosis
- (2013) Kevin Pethe et al. NATURE MEDICINE
- Identification of Novel Imidazo[1,2-a]pyridine Inhibitors Targeting M. tuberculosis QcrB
- (2013) Katherine A. Abrahams et al. PLoS One
- A Dual Read-Out Assay to Evaluate the Potency of Compounds Active against Mycobacterium tuberculosis
- (2013) Juliane Ollinger et al. PLoS One
- Advancement of Imidazo[1,2-a]pyridines with Improved Pharmacokinetics and nM Activity vs. Mycobacterium tuberculosis
- (2013) Garrett C. Moraski et al. ACS Medicinal Chemistry Letters
- Outwitting Evolution: Fighting Drug-Resistant TB, Malaria, and HIV
- (2012) Daniel E. Goldberg et al. CELL
- Antimycobacterial drugs currently in Phase II clinical trials and preclinical phase for tuberculosis treatment
- (2012) Jean Engohang-Ndong EXPERT OPINION ON INVESTIGATIONAL DRUGS
- New Drugs for the Treatment of Tuberculosis: Needs, Challenges, Promise, and Prospects for the Future
- (2012) Christian Lienhardt et al. JOURNAL OF INFECTIOUS DISEASES
- The non-human primate model of tuberculosis
- (2012) D. Kaushal et al. JOURNAL OF MEDICAL PRIMATOLOGY
- Modeling early bactericidal activity in murine tuberculosis provides insights into the activity of isoniazid and pyrazinamide
- (2012) J. Grosset et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Research Spotlight: The TB Alliance: overcoming challenges to chart the future course of TB drug development
- (2011) Ann Ginsberg Future Medicinal Chemistry
- A recombinant Mycobacterium smegmatis induces potent bactericidal immunity against Mycobacterium tuberculosis
- (2011) Kari A Sweeney et al. NATURE MEDICINE
- Advent of Imidazo[1,2-a]pyridine-3-carboxamides with Potent Multi- and Extended Drug Resistant Antituberculosis Activity
- (2011) Garrett C. Moraski et al. ACS Medicinal Chemistry Letters
- Global tuberculosis drug development pipeline: the need and the reality
- (2010) Zhenkun Ma et al. LANCET
- Tuberculosis control and elimination 2010–50: cure, care, and social development
- (2010) Knut Lönnroth et al. LANCET
- Multidrug-resistant and extensively drug-resistant tuberculosis: a threat to global control of tuberculosis
- (2010) Neel R Gandhi et al. LANCET
- Current development and future prospects in chemotherapy of tuberculosis
- (2010) Eric L. NUERMBERGER et al. RESPIROLOGY
- Paradoxical Effect of Isoniazid on the Activity of Rifampin-Pyrazinamide Combination in a Mouse Model of Tuberculosis
- (2009) D. Almeida et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Animal models of tuberculosis
- (2009) Douglas Young EUROPEAN JOURNAL OF IMMUNOLOGY
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started